Hangzhou Flariant Faces Financial Challenges Amid Valuation Adjustments and Declining Sales

Hangzhou Flariant Co., Ltd., a player in the specialty chemicals sector, has recently undergone an evaluation adjustment that reflects notable shifts in its financial metrics. The company has seen a revision in its score, attributed to changes in its valuation and technical indicators. The valuation metrics indicate a P/E ratio of 112 and a price-to-book value of 2.58, which suggest a complex financial landscape. The EV to EBITDA stands at 54.00, while the EV to sales ratio is recorded at 4.92. These figures highlight the company's positioning within its industry, although they also point to challenges in management efficiency, as evidenced by a low return on capital employed (ROCE) of 4.10% and a return on equity (ROE) of 2.30%. Despite these challenges, the company has reported a positive financial performance for the quarter ending March 2026. However, long-term growth remains a concern, with net sales experiencing a decline at an annual rate of -9.91% over the past five years. Overall, the adjustment in evaluation for Hangzhou Flariant Co., Ltd. underscores the complexities of its financial standing and market position. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.